Asarina Pharma AB (publ)

    Asarina Pharma AB (publ)

    SSTO:ASAP
    0.03
    SEK
    -0.01
    (-31.03%)
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    -3.97
    -2.75
    -3.85
    -4.02
    -1.69
    -0.71
    -0.57
    -0.93
    Free Cash Flow per Basic Share
    -3.51
    -2.23
    -3.43
    -4.24
    -2.27
    -0.5
    -0.5
    -1.19
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.25
    0.25
    -7.86
    -11.77
    -13.43
    -14
    -12.19
    -13.5
    Tangible Book Value per Share
    1.38
    8.72
    6.48
    2.81
    1.13
    0.78
    0.07
    1.03
    Basic Weighted Avg Shares
    7
    16
    18
    19
    19
    19
    23
    19
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    -28
    -44
    -71
    -75
    -32
    -13
    -13
    -17
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    10
    140
    118
    51
    20
    13
    1
    18
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    10
    140
    119
    53
    21
    15
    2
    19
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -1,520.46
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    SEK

    •

    in mil. unless spec.
    Dec'21
    Mar'22
    Jun'22
    ST Debt
    5
    - -
    - -
    LT Borrowings
    - -
    5
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    19
    19
    23
    Market Capitalization
    36
    34
    23

    Working Capital

    SEK

    •

    in mil. unless spec.
    Dec'21
    Mar'22
    Jun'22
    Total Current Assets
    29
    24
    20
    Cash, Cash Equivalents & STI
    22
    16
    12
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    9
    2
    2
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    5
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    SEK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -50.01%
    -88.71%
    Free Cash Flow
    - -
    -0.2%
    20.96%
    Net Income, GAAP
    - -
    -10.42%
    -3.43%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    -0.34
    -0.86
    -0.43
    - -
    -1.69
    2022
    -0.22
    -0.22
    - -
    - -
    -0.71
    2023
    - -
    - -
    - -
    - -
    -0.57

    Quarterly Dividends Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business